Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quercetin Phytosome in COVID-19
NCT04578158Phase 3Completed
- Sponsor
- Liaquat University of Medical and Health Sciences
- Start
- Sep 2020
- Primary completion
- Mar 2021
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Liaquat University of Medical and Health Sciences. Primary endpoint: Percentage of subjects with COVID-19 disease progression at 30 days. Started Sep 2020; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04578158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04578158.